Rebuttal From Drs Osgood and Muehlschlegel.
Sign Up to like & getrecommendations! Published in 2017 at "Chest"
DOI: 10.1016/j.chest.2017.08.1156
Abstract: We agree that there are very little data regarding the use of renal replacement therapy (RRT) in ABI, with a paucity of multicenter randomized controlled trials. When thoroughly evaluating the existing trials comparing CRRT to… read more here.
Keywords: drs osgood; rebuttal drs; osgood muehlschlegel;